Intrapleural use of tissue plasminogen activator and DNase in pleural infection
BACKGROUND: More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve outcomes in an earlier, large, randomized trial. METHODS: We conducted a blinded, 2-by-2 factor...
Главные авторы: | Rahman, N, Maskell, N, West, A, Teoh, R, Arnold, A, Mackinlay, C, Peckham, D, Davies, C, Ali, N, Kinnear, W, Bentley, A, Kahan, B, Wrightson, J, Davies, H, Hooper, C, Lee, Y, Hedley, E, Crosthwaite, N, Choo, L, Helm, E, Gleeson, F, Nunn, A, Davies, R |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2011
|
Схожие документы
-
Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
по: Rahman, N, и др.
Опубликовано: (2011) -
PRIMARY RESULT OF THE SECOND MULTICENTRE INTRAPLEURAL SEPSIS (MIST2) TRIAL; RANDOMISED TRIAL OF INTRAPLEURAL TPA AND DNASE IN PLEURAL INFECTION
по: Rahman, N, и др.
Опубликовано: (2009) -
The biological effect of tissue plasminogen (t-PA) activator and DNase intrapleural delivery in pleural infection patients
по: Kanellakis, N, и др.
Опубликовано: (2018) -
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
по: Kanellakis, N, и др.
Опубликовано: (2019) -
Intrapleural streptokinase for pleural infection.
по: Maskell, N, и др.
Опубликовано: (2006)